Clinical Trials Using Netupitant/Palonosetron Hydrochloride
Clinical trials are research studies that involve people. The clinical trials on this list are studying Netupitant/Palonosetron Hydrochloride. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
A Study to Assess the Safety and the Efficacy of IV Fosnetupitant / Palonosetron (260 mg / 0.25 mg) Combination Compared to Oral Netupitant / Palonosetron (300 mg / 0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer
Multicenter, randomized, double-blind, double-dummy, parallel group, stratified study assessing the safety and describing the efficacy of a single dose of intraveneous (IV) fosnetupitant / palonosetron (260 mg / 0.25 mg) infusion [test] versus oral netupitant / palonosetron (300 mg / 0.5 mg) combination [control]; each administered with oral dexamethasone prior to initial and repeated cycles of AC chemotherapy in female breast cancer patients.
Location: Cancer Therapy and Research Center at The UT Health Science Center at San Antonio, San Antonio, Texas